11.19
6.88%
0.72
시장 영업 전:
11.78
0.59
+5.27%
전일 마감가:
$10.47
열려 있는:
$10.55
하루 거래량:
226.82K
Relative Volume:
1.21
시가총액:
$265.42M
수익:
$315.66M
순이익/손실:
$-102.45M
주가수익비율:
-2.5374
EPS:
-4.41
순현금흐름:
$-30.25M
1주 성능:
+5.37%
1개월 성능:
+31.96%
6개월 성능:
+20.97%
1년 성능:
+109.16%
이노겐 Stock (INGN) Company Profile
명칭
Inogen Inc
전화
805-562-0500
주소
859 WARD DRIVE, GOLETA, CA
INGN을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
INGN
Inogen Inc
|
11.19 | 265.42M | 315.66M | -102.45M | -30.25M | -4.41 |
ABT
Abbott Laboratories
|
116.79 | 201.01B | 41.22B | 5.77B | 6.49B | 3.29 |
SYK
Stryker Corp
|
395.85 | 150.90B | 21.97B | 3.59B | 3.21B | 9.33 |
BSX
Boston Scientific Corp
|
100.91 | 148.72B | 15.91B | 1.79B | 1.89B | 1.21 |
MDT
Medtronic Plc
|
88.38 | 113.33B | 33.00B | 4.29B | 5.50B | 3.27 |
EW
Edwards Lifesciences Corp
|
69.97 | 41.27B | 6.60B | 4.16B | 490.10M | 6.93 |
이노겐 Stock (INGN) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2024-02-15 | 업그레이드 | William Blair | Mkt Perform → Outperform |
2023-08-08 | 다운그레이드 | JP Morgan | Overweight → Neutral |
2023-07-14 | 다운그레이드 | Needham | Buy → Hold |
2023-01-17 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
2021-12-09 | 업그레이드 | Needham | Hold → Buy |
2021-11-02 | 업그레이드 | JP Morgan | Underweight → Neutral |
2021-08-05 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
2021-06-04 | 업그레이드 | William Blair | Mkt Perform → Outperform |
2020-12-14 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
2020-07-23 | 다운그레이드 | Needham | Buy → Hold |
2020-05-06 | 재확인 | Needham | Buy |
2019-11-06 | 업그레이드 | Needham | Hold → Buy |
2019-09-13 | 재확인 | Piper Jaffray | Overweight |
2019-08-08 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
2019-08-08 | 다운그레이드 | Stifel | Buy → Hold |
2019-08-07 | 다운그레이드 | Needham | Buy → Hold |
2019-06-28 | 다운그레이드 | Needham | Strong Buy → Buy |
2019-05-08 | 다운그레이드 | JP Morgan | Overweight → Neutral |
2019-05-08 | 재확인 | Needham | Strong Buy |
2019-02-27 | 재확인 | Needham | Strong Buy |
2018-11-20 | 업그레이드 | Needham | Buy → Strong Buy |
2018-11-07 | 재확인 | Needham | Buy |
2018-09-10 | 다운그레이드 | Needham | Strong Buy → Buy |
2018-08-22 | 재개 | Stifel | Buy |
2018-08-08 | 재확인 | Needham | Strong Buy |
2018-06-06 | 개시 | KeyBanc Capital Mkts | Sector Weight |
2018-05-01 | 재확인 | Needham | Strong Buy |
2018-02-28 | 재확인 | Needham | Strong Buy |
모두보기
이노겐 주식(INGN)의 최신 뉴스
Inogen, Inc. (NASDAQ:INGN) Held Back By Insufficient Growth Even After Shares Climb 32% - Simply Wall St
Inogen, Inc. (NASDAQ:INGN) Short Interest Down 6.2% in December - MarketBeat
Inogen Stock Gains Following Solid Preliminary Q4 Revenues - MSN
Barclays PLC Purchases 23,398 Shares of Inogen, Inc. (NASDAQ:INGN) - Defense World
Inogen Insiders Benefitted From Selling Stock At US$8.56 - Simply Wall St
Inogen expects prelim Q4 revenue in the range of $79M to $80M - MSN
Inogen stock holds as revenue forecast beats consensus - Investing.com India
Inogen reports growth in Q4 and full year 2024 revenue By Investing.com - Investing.com Australia
Inogen stock holds as revenue forecast beats consensus By Investing.com - Investing.com Australia
Inogen (NASDAQ:INGN) Given "Hold" Rating at Needham & Company LLC - MarketBeat
Inogen, Inc. Provides Revenue Guidance for the Fourth Quarter of 2024 and Full Year 2024 - Marketscreener.com
Inogen, Inc. (NASDAQ:INGN) Stock Position Increased by JPMorgan Chase & Co. - Defense World
Inogen (NASDAQ:INGN) Stock Crosses Above Fifty Day Moving AverageHere's Why - MarketBeat
Inogen (NASDAQ:INGN) Stock Crosses Above Fifty Day Moving Average – Here’s Why - Defense World
Inogen reports growth in Q4 and full year 2024 revenue - Investing.com India
Inogen Surpasses 2024 Revenue Guidance with 6% Growth, Launches New Respiratory Products - StockTitan
Inogen receives FDA 510(k) clearance for SIMEOX 200 airway clearance device - News-Medical.Net
Jane Street Group LLC Cuts Stake in Inogen, Inc. (NASDAQ:INGN) - Defense World
Jane Street Group LLC Sells 250,473 Shares of Inogen, Inc. (NASDAQ:INGN) - MarketBeat
Geode Capital Management LLC Purchases 5,921 Shares of Inogen, Inc. (NASDAQ:INGN) - Defense World
Franklin Resources Inc. Takes $139,000 Position in Inogen, Inc. (NASDAQ:INGN) - Defense World
Inogen, Inc. (NASDAQ:INGN) Shares Purchased by Barclays PLC - Defense World
FDA OKs Inogen’s Simeox 200 Airway Clearance Device - MPO-mag
Inogen Stock Rises as FDA Clears SIMEOX 200 Airway Clearance Device - MSN
Inogen Expands U.S. Market with FDA Clearance - Yahoo Finance
FDA grants clearance for Inogen’s SIMEOX 200 airway clearance device - Yahoo Finance
Inogen Receives FDA 510(k) Clearance for SIMEOX 200 Airway Clearance Device - BioSpace
Inogen Gets FDA Clearance for Airway Clearance Device - MarketWatch
Inogen, Inc. (NASDAQ:INGN) Shares Purchased by State Street Corp - Defense World
Inogen's SIMEOX 200 Airway Clearance Device Receives FDA Clearance for Chronic Lung Disease Treatment - StockTitan
Here's Why You Should Retain Inogen Stock in Your Portfolio Now - Nasdaq
StockNews.com Downgrades Inogen (NASDAQ:INGN) to Hold - Defense World
Inogen, Inc. (NASDAQ:INGN) is a favorite amongst institutional investors who own 78% - Yahoo Finance
Inogen, Inc.'s (NASDAQ:INGN) institutional investors lost 12% over the past week but have profited from longer-term gains - Simply Wall St
Short Interest in Inogen, Inc. (NASDAQ:INGN) Grows By 6.7% - MarketBeat
BNP Paribas Financial Markets Increases Stock Position in Inogen, Inc. (NASDAQ:INGN) - Defense World
Inogen (NASDAQ:INGN) Raised to Buy at StockNews.com - Defense World
Respiratory Care Market Set to Witness Significant Growth by 2024-2031:Inogen, Inc., Honeywell International - EIN News
The Zacks Analyst Blog Intuitive Surgical, Globus Medical, Glaukos, Veracyte and Inogen - Yahoo Finance
Oxygen Concentrators Global Market Report: Market - openPR
Inogen Alliance Releases 2023 ESG Report - AccessWire
Respiratory Care Market Projected To Witness Substantial Growth, 2024-2031: Inogen, Inc., Honeywell - EIN News
Inogen (INGN) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - MSN
INGN (Inogen) Earnings per Share (Diluted) : $-2.25 (TTM As of Sep. 2024) - GuruFocus.com
Connor Clark & Lunn Investment Management Ltd. Buys 132,287 Shares of Inogen, Inc. (NASDAQ:INGN) - MarketBeat
이노겐 (INGN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
이노겐 주식 (INGN) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
Ramade Gregoire | Chief Commercial Officer |
Dec 01 '24 |
Option Exercise |
0.00 |
31,565 |
0 |
31,565 |
자본화:
|
볼륨(24시간):